Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine Sublingual Spray

buprenorphine · INSYS Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Buprenorphine Sublingual Spray, covering 2017-08-09 to 2018-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain [Phase 2]

See pricing